Literature DB >> 23539445

β-Catenin/POU5F1/SOX2 transcription factor complex mediates IGF-I receptor signaling and predicts poor prognosis in lung adenocarcinoma.

Chuan Xu1, Dan Xie, Shi-Cang Yu, Xiao-Jun Yang, Li-Ru He, Jing Yang, Yi-Fang Ping, Bin Wang, Lang Yang, Sen-Lin Xu, Wei Cui, Qing-Liang Wang, Wen-Juan Fu, Qing Liu, Cheng Qian, You-Hong Cui, Jeremy N Rich, Hsiang-Fu Kung, Xia Zhang, Xiu-Wu Bian.   

Abstract

Cancer stem-like cells (CSLC) are crucial in tumor initiation and progression; however, the underlying mechanism for the self-renewal of cancer cells remains undefined. In the study, immunohistochemical analysis of specimens freshly excised from patients with lung adenocarcinoma showed that high expression of insulin-like growth factor I receptor (IGF-IR) in lung adenocarcinoma cells was positively correlated with the expressions of cancer stem cell markers CD133 and aldehyde dehydrogenase 1 family member A1 (ALDH1A1). IGF-IR activation enhanced POU class 5 homeobox 1 (POU5F1) expression on human lung adenocarcinoma stem-like cells (LACSLC) through PI3K/AKT/GSK3β/β-catenin cascade. POU5F1 could form a novel complex with β-catenin and SOX2 to bind Nanog promoter for transcription to maintain self-renewal of LACSLCs, which was dependent on the functional IGF-IR. Genetic and pharmacologic inhibition of IGF-IR abrogated LACSLC capabilities for self-renewal and tumorigenicity in vitro. In an in vivo xenograft tumor model, knockdown of either IGF-IR or POU5F1 impeded tumorigenic potentials of LACSLCs. By analyzing pathologic specimens excised from 200 patients with lung adenocarcinoma, we found that colocalization of highly expressed IGF-IR with β-catenin and POU5F1 predicted poor prognosis. Taken together, we show that IGF-IR-mediated POU5F1 expression to form a complex with β-catenin and SOX2 is crucial for the self-renewal and oncogenic potentials of LACSLCs, and the integrative clinical detection of the expressions of IGF-IR, β-catenin, and POU5F1 is indicatory for predicting prognosis in the patients of lung adenocarcinoma. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23539445     DOI: 10.1158/0008-5472.CAN-12-4403

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  51 in total

1.  A meta-analysis of abnormal β-catenin immunohistochemical expression as a prognostic factor in lung cancer: location is more important.

Authors:  Y Yang; J Shen; Jiaxi He; Jianxing He; G Jiang
Journal:  Clin Transl Oncol       Date:  2015-10-12       Impact factor: 3.405

2.  Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor.

Authors:  Shan Zeng; Adrian M Seifert; Jennifer Q Zhang; Michael J Cavnar; Teresa S Kim; Vinod P Balachandran; Juan A Santamaria-Barria; Noah A Cohen; Michael J Beckman; Benjamin D Medina; Ferdinand Rossi; Megan H Crawley; Jennifer K Loo; Joanna H Maltbaek; Peter Besmer; Cristina R Antonescu; Ronald P DeMatteo
Journal:  Mol Cancer Ther       Date:  2017-06-13       Impact factor: 6.261

3.  SOX5 interacts with YAP1 to drive malignant potential of non-small cell lung cancer cells.

Authors:  Hongbo Zou; Shuang Wang; Songtao Wang; Hong Wu; Jing Yu; Qian Chen; Wei Cui; Ye Yuan; Xianmei Wen; Jian He; Lin Chen; Ruilian Yu; Ming Zhang; Haitao Lan; Guoxiang Jin; Xia Zhang; Xiuwu Bian; Chuan Xu
Journal:  Am J Cancer Res       Date:  2018-05-01       Impact factor: 6.166

4.  Cationic lipoplexes for treatment of cancer stem cell-derived murine lung tumors.

Authors:  Terrick Andey; Namrata Bora-Singhal; Srikumar P Chellappan; Mandip Singh
Journal:  Nanomedicine       Date:  2019-03-01       Impact factor: 5.307

Review 5.  Implications of Insulin-like Growth Factor 1 Receptor Activation in Lung Cancer.

Authors:  Fariz Nurwidya; Sita Andarini; Fumiyuki Takahashi; Elisna Syahruddin; Kazuhisa Takahashi
Journal:  Malays J Med Sci       Date:  2016-05

6.  Bruton tyrosine kinase is a therapeutic target in stem-like cells from multiple myeloma.

Authors:  Ye Yang; Jumei Shi; Zhimin Gu; Mohamed E Salama; Satyabrata Das; Erik Wendlandt; Hongwei Xu; Junwei Huang; Yi Tao; Mu Hao; Reinaldo Franqui; Dana Levasseur; Siegfried Janz; Guido Tricot; Fenghuang Zhan
Journal:  Cancer Res       Date:  2015-01-14       Impact factor: 12.701

Review 7.  Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis.

Authors:  Shuang Zhao; Zhixin Qiu; Jinlan He; Lei Li; Weimin Li
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

8.  PRKCZ-AS1 promotes the tumorigenesis of lung adenocarcinoma via sponging miR-766-5p to modulate MAPK1.

Authors:  Ming Wang; Qin Liao; Pengfei Zou
Journal:  Cancer Biol Ther       Date:  2020-01-15       Impact factor: 4.742

9.  Mechanically tunable coaxial electrospun models of YAP/TAZ mechanoresponse and IGF-1R activation in osteosarcoma.

Authors:  Eric R Molina; Letitia K Chim; Maria C Salazar; Shail M Mehta; Brian A Menegaz; Salah-Eddine Lamhamedi-Cherradi; Tejus Satish; Sana Mohiuddin; David McCall; Ana Maria Zaske; Branko Cuglievan; Alexander J Lazar; David W Scott; Jane K Grande-Allen; Joseph A Ludwig; Antonios G Mikos
Journal:  Acta Biomater       Date:  2019-09-19       Impact factor: 8.947

10.  NF-κB-driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance.

Authors:  Ching-Feng Chiu; Yi-Wen Chang; Kuang-Tai Kuo; Yu-Shiuan Shen; Chien-Ying Liu; Yang-Hao Yu; Ching-Chia Cheng; Kang-Yun Lee; Feng-Chi Chen; Min-Kung Hsu; Tsang-Chih Kuo; Jui-Ti Ma; Jen-Liang Su
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.